This Review describes interactions between intrahepatic cholangiocarcinoma cells and the surrounding stroma, with a focus on myofibroblastic cells. A 'human-like' orthotopic rat model and a new organotypic culture system have been developed, which can be used to test new therapies. Novel combination approaches to treatment that target both the cancer cells and cancer-promoting stromal cells are discussed.
